Pictet Asset Management
IRWD icon

Pictet Asset Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Pictet Asset Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-16,495
Closed -$24.2K – 2031
2025
Q1 		$24.2K Hold
16,495
– – ﹤0.01% 2003
2024
Q4 		$73.1K Hold
16,495
– – ﹤0.01% 2002
2024
Q3 		$68K Hold
16,495
– – ﹤0.01% 1975
2024
Q2 		$108K Hold
16,495
– – ﹤0.01% 1874
2024
Q1 		$144K Hold
16,495
– – ﹤0.01% 1826
2023
Q4 		$189K Hold
16,495
– – ﹤0.01% 1768
2023
Q3 		$159K Buy
+16,495
New +$162K ﹤0.01% 1739

Other funds holding IRWD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Pictet Asset Management's IRWD Position: Q2 2025 in Review

Pictet Asset Management sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2025, closing a stake of 16,495 shares — an estimated $24.2K sold.

Pictet Asset Management first reported a position in IRWD in Q3 2023 and held it in 7 quarters. The position peaked at $189K in Q4 2023. 155 funds tracked by Wall St. Rank hold IRWD as of Q2 2025.

  • Pictet Asset Management reported no remaining Ironwood Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Pictet Asset Management sold 16,495 Ironwood Pharmaceuticals shares in Q2 2025, an estimated $24.2K.
  • Pictet Asset Management first reported a position in Ironwood Pharmaceuticals in Q3 2023 and held it in 7 quarters.
  • Pictet Asset Management's Ironwood Pharmaceuticals position peaked at $189K in Q4 2023.
  • 155 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2025.

Based on Pictet Asset Management's 13F filing for Q2 2025, filed 13 Aug 2025.